Omeros Corporation logo

Omeros Corporation

NASDAQ:OMER

Overview | Financials
Company Name Omeros Corporation
Symbol OMER
Currency USD
Price 3.3
Market Cap 191,215,860
Dividend Yield 0%
52-week-range 0.92 - 7.8
Industry Biotechnology
Sector Healthcare
CEO Dr. Gregory A. Demopulos M.D.
Website https://www.omeros.com

An error occurred while fetching data.

About Omeros Corporation

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated

Related Stocks

Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.

CODX

1.01 USD

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

INZY

4.51 USD

Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc.

MIST

1.56 USD

OptiNose, Inc. logo

OptiNose, Inc.

OPTN

1.07 USD

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

0.74 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

3.7 USD

Financials

Numbers are in millions USD

Numbers are in millions USD